Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI

Rockwell Med (RMTI) Income Statement

962 Followers

Rockwell Med Income Statement

Last quarter (Q1 2024), Rockwell Med's total revenue was $22.68M, an increase of Infinity% from the same quarter last year. In Q1, Rockwell Med's net income was $-1.73M. See Rockwell Med’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 86.62M$ 83.61M$ 72.81M$ 61.93M$ 62.20M$ 61.30M
Cost of Revenue
$ 77.45M$ 74.91M$ 68.73M$ -64.35M$ 59.47M$ 58.46M
Gross Profit
$ 9.17M$ 8.70M$ 4.08M$ -2.42M$ 2.73M$ 2.84M
Operating Expense
$ 15.73M$ 15.37M$ 20.84M$ 27.88M$ 31.14M$ 36.93M
Operating Income
$ -6.57M$ -6.67M$ -16.78M$ -92.23M$ -28.42M$ -34.09M
Net Non Operating Interest Income Expense
$ -2.13M$ -2.09M$ -1.90M$ -2.34M$ -1.64M$ 367.00K
Other Income Expense
$ -281.00K$ -321.00K$ -4.00K$ -61.93M$ -829.00K$ -400.00K
Pretax Income
$ -8.41M$ -8.43M$ -18.66M$ -32.64M$ -30.89M$ -34.13M
Tax Provision
---$ 0.00--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.42M$ -8.44M$ -18.68M$ -32.64M$ -30.89M$ -34.13M
Basic EPS
$ -0.33$ -0.37$ -1.89$ -0.35$ -4.51$ -0.56
Diluted EPS
$ -0.33$ -0.37$ -1.89$ -0.35$ -4.51$ -0.56
Basic Average Shares
$ 104.26M$ 23.32M$ 9.87M$ 93.79M$ 6.87M$ 60.92M
Diluted Average Shares
$ 104.26M$ 23.32M$ 9.87M$ 93.79M$ 6.87M$ 60.92M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 93.18M$ 90.28M$ 89.57M$ -36.47M$ 90.62M$ 95.40M
Net Income From Continuing And Discontinued Operation
$ -8.42M$ -8.44M$ -18.68M$ -32.64M$ -30.89M$ -34.13M
Normalized Income
$ -2.90M$ -6.66M--$ -30.90M$ -34.16M
Interest Expense
----$ 1.88M$ 25.00K
EBIT
$ -6.08M$ -6.14M$ -16.72M$ -30.30M$ -29.01M$ -34.10M
EBITDA
$ -2.28M$ -4.69M$ -13.77M$ -27.42M$ -26.72M$ -31.45M
Currency in USD

Rockwell Med Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis